Mingo Junction senior center goes pink, benefits children with cancer | News, Sports, Jobs
MINGO JUNCTION — The Mingo Junction Senior Center was decked out in pink for a breast cancer awareness and benefit event, raising money to buy gifts for child
Stay updated with breaking news from Mark Trombetta. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MINGO JUNCTION — The Mingo Junction Senior Center was decked out in pink for a breast cancer awareness and benefit event, raising money to buy gifts for child
GammaPod is a radiation device specifically designed for the treatment of breast cancer, delivering high doses of targeted radiation to the tumor, while sparing the surrounding uninvolved breast tissue and nearby critical organs, such as the heart and lungs
PITTSBURGH, PA (PRWEB) February 17, 2022 -- Over her years of faithfully getting annual mammograms, it wasn’t uncommon for Patti Mannarino to get a call-back
Message : Required fields Lantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus), an established leader and fully integrated provider of innovative imaging diagnostics, targeted therapeutics and artificial intelligence solutions to Find, Fight and Follow serious medical conditions, today announced a strategic collaboration with Allegheny Health Network (AHN), a western Pennsylvania healthcare delivery system headquartered in Pittsburgh, PA. Under the agreement, Lantheus’ microbubbles will be used in combination with AHN’s ultrasound-assisted non-viral gene transfer (UAGT) technology for the de...
Allegheny General Hospital Physicians Among the First in the Country to Use Novel Radiation Therapy to Treat Severe Heart Arrhythmias Share Article A team of physicians at Allegheny General Hospital, part of Allegheny Health Network, are among the first in the country to use a novel form of radiation therapy to treat a life-threatening heart rhythm disorder known as ventricular tachycardia. Radiation oncologist Mark Trombetta, MD, and cardiac electrophysiologist Emerson Liu, MD, are principal investigators in the trial. “Our goal is to establish this therapy through a broader experience as ...